REG vs TGTX · P/E 34, rev $1.45B vs P/E 18, rev $240.3M
Regency Centers Corporation (REG) versus TG Therapeutics Inc (TGTX) — a side-by-side from cached financials, not a winner call.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
TG Therapeutics Inc (TGTX) is a biotechnology company listed on NASDAQ.
Latest reported REG revenue for 2024-12-31 was $1.45B. Net income was $409.8M. Revenue was up 9.9% from 2023-12-31 to 2024-12-31. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Latest reported TGTX revenue for 2026-06-30 was $240.3M. Net income was $7.8M. Revenue was up 17.3% from 2026-03-31 to 2026-06-30. TGTX currently screens at market cap $7.88B and trailing P/E 18.0.
REG currently screens at market cap $12.93B and trailing P/E 33.5. TGTX currently screens at market cap $7.88B and trailing P/E 18.0.
Not investment advice. Open the REG and TGTX stock pages for the full models.
Not investment advice.